Contemplation on Polycystic Ovarian Syndrome

Aanandhi  VN; Gayathri N

Aanandhi VN Ph D Scholar, Ranimeyyammai College of Nursing, Chidambaram, Tamil Nadu, India.
Gayathri N Lecturer, Ranimeyyammai College of Nursing, Chidambaram, Tamil Nadu, India.

Keywords: Polycystic Ovarian Syndrome, Hormonal Imbalance, Hyperandrogenism, Anovulation, Insulin Resistance, Oral Contraceptive Pills, Progestin therapy, Lifestyle Modification

Abstract

Polycystic ovary syndrome (PCOS), also called Stein-Leventhal syndrome, is a metabolic disorder. It affects 4-20% of women globally. According to the National Health Portal Report 2016, the estimated prevalence of PCOS by Rotterdam’s criteria was 9.13% in South India. If not monitored in time, the condition can have severe health impacts. The underlying cause of PCOS is known. Genetic inheritance, poor lifestyle, fast food intake, sedentary lifestyle, and obesity all invariably influence the risk of PCOS. Imbalanced hormonal activity increases LH:FSH ratio, androgen excess, and insulin resistance causing polycystic ovaries and anovulation. Affected clients present with clinical signs of hyperandrogenism like acne, hirsutism, alopecia, acanthosis nigricans, irregular periods, anxiety, depression, stress, etc. Rotterdam criteria, the Androgen excess society, American Association of Clinical Endocrinologists (AACE) diagnose PCOS based on anovulation, hyperandrogenism, and polycystic ovaries. Management of PCOS includes oral contraceptive pills, progestin therapy, ovulatory stimulants, insulin-sensitising agents, antiandrogens, and vitamin D. In addition to this, lifestyle modification with good dietary changes, moderate exercise, and stress management also yield positive results in reverting PCOS.

How to cite this article:
Aanandhi VN, Gayathri N. Contemplation on Polycystic Ovarian Syndrome. Int J Preven Curat Comm Med. 2022;8(3&4):17-22.

DOI: https://doi.org/10.24321/2454.325X.202208

References

Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev

Endocrinol. 2018;14(5):270. [PubMed] [Google Scholar]

Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020;13(4):261-71. [PubMed] [Google Scholar]

Liu J, Wu Q, Hao Y, Jiao M, Wang X, Jiang S, Han L. Measuring the global disease burden of polycystic

ovary syndrome in 194 countries: Global Burden of Disease Study 2017. Hum Reprod. 2021;36(4):1108-19.

[PubMed] [Google Scholar]

Ganie MA, Vasudevan V, Wani IM, Baba MS, Arif T, Rashid A. Epidemiology, pathogenesis, genetics &

management of polycystic ovary syndrome in India. Indian J Med Res. 2019;150(4):333-44. [PubMed]

[Google Scholar]

National Health Portal of India [Internet]. Polycystic ovary syndrome (PCOS); 2016 [cited 2022 Nov 10].

Available from: nhp.gov.in/disease/endocrinal/ovaries/polycystic-ovarysyndrome-pco

Goyal A, Ganie MA. Idiopathic hyperprolactinemia presenting as polycystic ovary syndrome in identical twin sisters: a case report and literature review. Cureus. 2018 Jul 19;10(7):e3004.

[PubMed] [Google Scholar]

Albu D, Albu A. The relationship between anti-Müllerian hormone serum level and body mass index in a large cohort of infertile patients. Endocrine. 2019;63(1):157-63. [PubMed] [Google Scholar]

Spinedi E, Cardinali DP. The polycystic ovary syndrome and the metabolic syndrome: a possible chronobiotic-cytoprotective adjuvant therapy. Int J Endocrinol. 2018;2018:1349868. [PubMed] [Google Scholar]

Puttabyatappa M, Padmanabhan V. Ovarian and extraovarian mediators in the development of polycystic ovary syndrome. J Mol Endocrinol. 2018;61(4):R161-84. [PubMed] [Google Scholar]

Ashraf S, Aslam R, Bashir I, Majeed I, Jamshaid M. Environmental determinants and PCOS symptoms

severity: a cross-sectional study. Health Care Women Int. 2022;43(1-3):98-113. [PubMed] [Google Scholar]

Shan B, Cai JH, Yang SY, Li ZR. Risk factors of polycystic ovarian syndrome among Li people. Asian Pac J Trop

Med. 2015;8(7):590-3. [PubMed] [Google Scholar]

Wang L, Lv S, Li F, Yu X, Bai E, Yang X. Vitamin D deficiency is associated with metabolic risk factors

in women with polycystic ovary syndrome: a crosssectional study in Shaanxi China. Front Endocrinol

(Lausanne). 2020;11:171. [PubMed] [Google Scholar]

Witchel SF, Oberfield SE, Peña AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment

with emphasis on adolescent girls. J Endocr Soc. 2019 Aug 1;3(8):1545-73. [PubMed] [Google Scholar]

Manu, Soni T, Victoria, Prabhakar PK. Pathophysiology of polycystic ovarian syndrome. In: Wang Z, editor.

Polycystic ovary syndrome - functional investigation and clinical application. Intech Open; 2022.

Ndefo UA, Eaton A, Green MR. Polycystic ovary syndrome: a review of treatment options with a focus on

pharmacological approaches. P T. 2013 Jun;38(6):336-38, 348, 355. [PubMed] [Google Scholar]

de Medeiros SF, Yamamoto MM, de Medeiros MA, Barbosa BB, Soares JM, Baracat EC. Changes in clinical

and biochemical characteristics of polycystic ovary syndrome with advancing age. Endocr Connect.

;9(2):74-80. [PubMed] [Google Scholar]

Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the

Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with

metabolic factors. BJOG. 2006;113(10):1210-7. [PubMed] [Google Scholar]

Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE,

Legro RS, Norman RJ, Taylor AE, Wichel SF. The Androgen Excess and PCOS Society criteria for the

polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009 Feb;91(2):456-88. [PubMed]

[Google Scholar]

Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of

Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society

(AES). American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen

Excess and PCOS Society Disease State Clinical Review:guide to the best practices in the evaluation and

treatment of polycystic ovary syndrome--part 1. Endocr Pract. 2015 Nov;21(11):1291-300. [PubMed] [Google

Scholar]

Palomba S, Santagni S, Falbo A, La Sala GB. Complications and challenges associated with polycystic

ovary syndrome: current perspectives. Int J Womens Health. 2015;7:745-63. [PubMed] [Google Scholar]

Ruan X, Li M, Mueck AO. Why does polycystic ovary syndrome (PCOS) need long-term management? Curr

Pharm Des. 2018;24(39):4685-92. [PubMed] [Google Scholar]

Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: what’s new? Adv Clin Exp Med. 2017;26(2):359-67. [PubMed] [Google Scholar]

Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies.

Cell Metab. 2014;20(6):953-66. [PubMed] [Google Scholar]

Fang F, Ni K, Cai Y, Shang J, Zhang X, Xiong C. Effect of vitamin D supplementation on polycystic ovary

syndrome: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Clin

Pract. 2017;26:53-60. [PubMed] [Google Scholar]

Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ; International PCOS

Network. Recommendations from the international evidence-based guideline for the assessment and

management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364-79. [PubMed]

Dou L, Zheng Y, Li L, Gui X, Chen Y, Yu M, Guo Y. The effect of cinnamon on polycystic ovary syndrome in

a mouse model. Reprod Biol Endocrinol. 2018 Oct 19;16(1):99. [PubMed] [Google Scholar]

Dou L, Zheng Y, Li L, Gui X, Chen Y, Yu M, Guo Y. The effect of cinnamon on polycystic ovary syndrome in

a mouse model. Reprod Biol Endocrinol. 2018;16:99. [PubMed] [Google Scholar]

Nowak DA, Snyder DC, Brown AJ, Demark-Wahnefried W. The effect of flaxseed supplementation on hormonal levels associated with polycystic ovarian syndrome: a case study. Curr Top Nutraceutical Res. 2007;5(4):177-81. [PubMed] [Google Scholar]

Shamsi M, Nejati V, Najafi G, Pour SK. Protective effects of licorice extract on ovarian morphology, oocyte

maturation, and embryo development in PCOS-induced mice: an experimental study. Int J Reprod Biomed

[Internet]. 2020;18(10):865-76. [PubMed] [Google Scholar]

Swaroop A, Jaipuriar AS, Gupta SK, Bagchi M, Kumar P, Preuss HG, Bagchi D. Efficacy of a novel fenugreek

seed extract (Trigonella foenum-graecum, FurocystTM) in polycystic ovary syndrome (PCOS). Int J Med Sci.

;12(10):825-31. [PubMed] [Google Scholar]

Douglas CC, Gower BA, Darnell BE, Ovalle F, Oster RA, Azziz R. Role of diet in the treatment of polycystic

ovary syndrome. Fertil Steril. 2006 Mar;85(3):679-88. [PubMed] [Google Scholar]

Shetty D, Chandrasekaran B, Singh AW, Oliverraj J. Exercise in polycystic ovarian syndrome: an evidencebased

review. Saudi J Sports Med. 2017;17(3):123. [Google Scholar]

Shele G, Genkil J, Speelman D. A systematic review of the effects of exercise on hormones in women with

polycystic ovary syndrome. J Funct Morphol Kinesiol. 2020;5(2):35. [PubMed] [Google Scholar]